NasdaqGM - Nasdaq Real Time Price USD

SI-BONE, Inc. (SIBN)

Compare
16.31 +0.25 (+1.56%)
At close: 4:00 PM EDT
16.31 0.00 (0.00%)
After hours: 4:02 PM EDT
Loading Chart for SIBN
DELL
  • Previous Close 16.06
  • Open 16.08
  • Bid 16.29 x 100
  • Ask 16.35 x 200
  • Day's Range 15.89 - 16.71
  • 52 Week Range 11.76 - 23.25
  • Volume 150,479
  • Avg. Volume 357,563
  • Market Cap (intraday) 680.031M
  • Beta (5Y Monthly) 1.20
  • PE Ratio (TTM) --
  • EPS (TTM) -1.00
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 23.56

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

si-bone.com

344

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SIBN

View More

Performance Overview: SIBN

Trailing total returns as of 8/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SIBN
22.30%
S&P 500
17.24%

1-Year Return

SIBN
23.82%
S&P 500
26.14%

3-Year Return

SIBN
31.61%
S&P 500
24.01%

5-Year Return

SIBN
15.14%
S&P 500
93.63%

Compare To: SIBN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SIBN

View More

Valuation Measures

Annual
As of 8/28/2024
  • Market Cap

    669.61M

  • Enterprise Value

    556.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.35

  • Price/Book (mrq)

    4.06

  • Enterprise Value/Revenue

    3.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -27.10%

  • Return on Assets (ttm)

    -12.51%

  • Return on Equity (ttm)

    -23.88%

  • Revenue (ttm)

    150.71M

  • Net Income Avi to Common (ttm)

    -40.85M

  • Diluted EPS (ttm)

    -1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    151.53M

  • Total Debt/Equity (mrq)

    23.32%

  • Levered Free Cash Flow (ttm)

    -11.71M

Research Analysis: SIBN

View More

Company Insights: SIBN

Research Reports: SIBN

View More

People Also Watch